BARCLAYS PLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2022$18,000
-95.1%
14,104
-93.3%
0.00%
Q4 2021$370,000
+245.8%
210,896
+327.7%
0.00%
Q3 2021$107,000
-48.3%
49,306
-16.4%
0.00%
Q2 2021$207,000
-88.3%
58,987
-67.1%
0.00%
-100.0%
Q1 2021$1,767,000
-44.7%
179,246
-39.2%
0.00%
-50.0%
Q4 2020$3,194,000
-21.7%
294,782
-25.6%
0.00%0.0%
Q3 2020$4,081,000
-30.9%
396,025
+40.0%
0.00%
-60.0%
Q2 2020$5,905,000
+124.9%
282,820
+5.3%
0.01%
+150.0%
Q1 2020$2,626,000
-50.8%
268,681
-42.0%
0.00%
-33.3%
Q4 2019$5,338,000
+2069.9%
463,238
+927.1%
0.00%
Q3 2019$246,000
-75.6%
45,101
-46.9%
0.00%
Q2 2019$1,008,000
+290.7%
84,880
+72.9%
0.00%
Q1 2019$258,000
+360.7%
49,085
+174.9%
0.00%
Q4 2018$56,000
-86.6%
17,857
-74.2%
0.00%
Q3 2018$418,000
+257.3%
69,135
+211.9%
0.00%
Q2 2018$117,000
-79.0%
22,164
-76.9%
0.00%
Q1 2018$556,000
+363.3%
95,883
+178.4%
0.00%
Q4 2017$120,000
+650.0%
34,445
+674.9%
0.00%
Q3 2017$16,000
-94.4%
4,445
-96.1%
0.00%
Q2 2017$285,000
+714.3%
113,978
+756.8%
0.00%
Q1 2017$35,000
+25.0%
13,303
+36.0%
0.00%
Q4 2016$28,0009,781
+488950.0%
0.00%
Q3 2016$0
-100.0%
2
-99.6%
0.00%
Q2 2016$1,0004950.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2019
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders